24_10_STREAM_SiteHeader_OP

2025 CDMO LEADERSHIP AWARDS CEREMONY

Now in its 14th year, the CDMO Leadership Awards, presented by Outsourced Pharma and brought to you by Life Science Connect with research by Orientation Marketing, highlight the industry’s most valued partners, as determined by the customers who use their services. This year’s awards ceremony introduced new categories and many new winners, based on enhanced scoring methodology, and a refined approach based on customer feedback.

Watch our on-demand broadcast of the event that took place on March 19th, 2025 at The POOL in New York City to share in the celebration of the best in the industry!

 

RECENT WEBINARS

54:53 GettyImages-1214112149-lab-team-collaboration-research

Solving The Inhalation Puzzle: A CDMO's Guide To Dry Powder Development

1:05:37 CRISPR Meets LNPs: A New Era In Cell And Gene Therapies

CRISPR Meets LNPs: A New Era In Cell And Gene Therapies

59:47 GettyImages-2174865907 workflow, lab, cell therapy

Transposase-Enabled CLD: From Transfection To High Titer With Ease

54:08 Scaling Up Your E. Coli pDNA Process From Parameter Screening To Pilot Scale

Scaling Up Your E. Coli pDNA Process From Parameter Screening To Pilot Scale

1:02:22 CAI - operational readiness webinar

The Pathway To Operational Readiness

58:02 rules, policies, regulatory documents-GettyImages-1438925546

Navigating The New USP Chapter <382> For Elastomeric Closures

51:33 catalent uptempo thumb

UpTempo℠: Seamless Transitions From Bench To CGT Applications

47:35 GettyImages-1214921728-lab-glassware-beaker-vial-test-tube

Unlocking Efficiency In Large-Scale Microbial Manufacturing

1:01:16 abzena understanding webinar thumb

The Role Of Developability In Lead Candidate Selection

1:02:00 GettyImages-1371925389-lab-scientist-collaboration-computer-clipboard

Optimizing The Progression Of Biotherapeutic Candidates To FIH Studies

34:43 GettyImages-1218359147 Subcutaneous injection

A New Look At Subcutaneous mAb Delivery Using Nanoformed Particles

35:47 HERMA - labeling webinar

How To Optimize Labeling In A Pharmaceutical Environment

More Recent Webinars

SMALL MOLECULE OUTSOURCING

3:43 Kelly McGuill

Cambrex Scientist Spotlight: Kelly McGuill

1:07:26 Achieving Desired Particle Size And Yield Through Efficient Micronization

Achieving Desired Particle Size And Yield Through Efficient Micronization

49:57 molecules

Rapid Developability Assessment Of Early Phase Molecules

4:20 Adare-Feature

Developing Long-Acting Contraceptive Injectables

5:04 Adare Pessano Tour

Adare Pharma Solutions Pessano Site Tour

50:18 West-SBO 1 - GC_APP_3e FunShot_4

A Data-Driven Approach To Container Closure Integrity

1:00:17 Lonza-1

Challenges Of Moving A Bioconjugate Candidate From Clinic To Market

1:01:17 GettyImages-1354172420-lab-development

Taste Masking 101: Applications And Technologies

1:00:00 alcami nitro web thumb

Understanding Nitrosamines: Key Regulations And Best Practices

1:00:30 GettyImages-1182436133 scientist, lab, research, oncology

Accelerating Clinical Development: Modern Tools In Process Chemistry

14:57 GettyImages-1938554519-lab-computer-research-discovery

Improve The Performance Of Your Small And Large Molecule Medicines

56:09 Cleanroom Faciliy GettyImages-1087218962

From Bench To Batch: Strategies For Scaling HPAPI Production

More Small Molecule Outsourcing Videos
24_10_STREAM_Brand_Category_Banner_LONZA_top v2
13:11 Lab GettyImages-1291031461

Hybrid Approach For Optimizing Transient Protein Expression In CHO Cells

1:00:24 GettyImages-517743436-plasmid-dna-development-lab

Tailored CMC Solutions That Meet Needs Of Novel Molecular Biologic Formats

1:02:23 1_C8B732D52BE7E51733E89B25739EA64C

Achieving Biologics License Application Success Using A Structured Approach

1:00:17 Lonza-1

Challenges Of Moving A Bioconjugate Candidate From Clinic To Market

27:13 Modern-Medical-Research-Lab-GettyImages-1293773029

Improved Design And Production Of Bispecific Therapeutics

13:51 GettyImages-1346675522-lab-team-microscope-computer-collaboration

The CDMO Value Proposition For Your Autologous Cell Therapy

1:00:30 GettyImages-1182436133 scientist, lab, research, oncology

Accelerating Clinical Development: Modern Tools In Process Chemistry

59:10 GettyImages-1404945060 Medical Lab

Effective Technology Transfer For Mammalian Derived Biopharmaceuticals

14:47 GettyImages-1441662840-lab-team-communication-collaboration

Precision Execution Of Bispecifics At Scale From Design To Delivery

49:07 GettyImages-597971944-viral-vector-AAV-adeno-associated-virus

Improved And Rebalanced Plasmids To Ramp Up Your AAV Productivity

1:02:12 Lonza-webinar1

Identifying And Mitigating Potential For Immunogenicity, Immunotoxicity

48:58 Lonza2

Mitigate Risk Of Failure In Biotherapeutic Development

More Lonza Videos
24_10_STREAM_Brand_Category_Banner_LONZA_bottom v2

CELL AND GENE OUTSOURCING

48:47 GettyImages-1441786721-mAb-Antibody-monoclonal

Optimizing Monoclonal Antibody Manufacturing For Commercial Success

1:16:51 West-PFS SYRG-018

Managing Risks In Injectable Drug Delivery

1:00:24 GettyImages-517743436-plasmid-dna-development-lab

Tailored CMC Solutions That Meet Needs Of Novel Molecular Biologic Formats

13:51 GettyImages-1346675522-lab-team-microscope-computer-collaboration

The CDMO Value Proposition For Your Autologous Cell Therapy

52:26 Mastering The Art Of Developing A Successful Bispecific Antibody

Mastering The Art Of Developing A Successful Bispecific Antibody

45:51 GettyImages-166021085 cell and gene

Candidate Screening And Feasibility Studies For Viral Gene Therapies

58:28 GettyImages-155372946-cold-chain-cryopreservation-logistics

Cryopreservation Best Practices For Cell & Gene Therapy Source Material

29:40 Mastering the journey

Mastering The Journey From Initial Method Transfer To Successful Lot Release For Cell & Gene Therapies

49:07 GettyImages-597971944-viral-vector-AAV-adeno-associated-virus

Improved And Rebalanced Plasmids To Ramp Up Your AAV Productivity

49:07 IDT Biologika - Vaccine Feature

Viral Vector Manufacturing: Improve Efficiency With A Platform Approach

50:05 West

Selecting Containers For Sensitive And Costly Cell & Gene Therapies

4:16 WuXi Advanced Therapies Philadelphia Campus Overview

Minaris Advanced Therapies Philadelphia Campus Overview

More Cell and Gene Outsourcing Videos

OUTSOURCED PHARMA CAPACITY UPDATE

24:29 Catalent April OPCU FF

Catalent Capacity Update April 2025: Fill/Finish

20:54 Bora April OPCU FF

Bora Pharmaceuticals Capacity Update April 2025: Fill/Finish

18:35 Simtra April OPCU FF

Simtra Biopharma Solutions Capacity Update April 2025: Fill/Finish

23:38 Mabion April OPCU FF

Mabion Capacity Update April 2025: Fill/Finish

19:20 Resilience April OPCU FF

Resilience Capacity Update April 2025: Fill/Finish

18:15 Curia April OPCU FF

Curia Capacity Update April 2025: Fill/Finish

22:08 IDT Biologika April OPCU FF

IDT Biologika Capacity Update April 2025: Fill/Finish

21:52 FUJI April OPCU FF

FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Fill/Finish

22:23 Argonaut April OPCU FF

Argonaut Capacity Update April 2025: Fill/Finish

20:18 FUJI April OPCU CG

FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Cell & Gene Therapy

24:55 VintaBio April OPCU CG

Vinta Bio Capacity Update April 2025: Cell & Gene Therapy

20:03 Kincell April OPCU CG

Kincell Bio Capacity Update April 2025: Cell & Gene Therapy

Outsourced Pharma Capacity Update Page

BIOLOGIC OUTSOURCING

1:09 GettyImages-1444551560-filling-aseptic-fill-finish-line

Handle Your Drug Product With The Highest Quality And Safety

2:27 1

Delivering Therapies To Patients At Scale And At Speed

23:33 fuji safety thumb

Building A Strong Safety Culture In The Biopharmaceutical Industry

1:52 iStock-879831370-plasmid-lab-cell

Rising To Meet Increasing Demand For Microbial Based Biologics

21:33 abzena october opcu

Abzena Capacity Update October 2024: ADC

1:35 Ampoule Aseptic Filling GettyImages-1490244818

Delivering Top Quality Fill Finish Manufacturing

13:18 abzena cc AbZelectPRO thumb

The Next-Gen Cell Line Development Platform Fueling Biologics Success

1:32 GettyImages-2036497686-lab-team-collaboration-laboratory-tablet-computer

Discovering A Unique Multimillion Euro Nanotechnology Facility

1:19 Expertise In Commercial Fill-Finish For More Than 30 Years

Expertise In Commercial Fill-Finish For More Than 30 Years

1:39 Aji OPTIMA 7000

OPTIMA 7000 Fill Line

0:44 Meeting Needs And Exceeding Expectations Worldwide

Meeting Needs And Exceeding Expectations Worldwide

1:43 GettyImages-1297146235-dna

Providing Value Optimized, Time Saving Oligo Solutions

More Biologic Outsourcing Videos

OUTSOURCED PHARMA LIVE

4:57 25_06_OPL_1280x720_Seg11

The World Outside Influencing Your Outsourcing Internals

2:06 25_06_OPL_1280x720_Seg10

Creating Your ADC Supply Chain

4:02 25_06_OPL_1280x720_Seg06

Your CDMO Knows A Lot - Are You Listening?

4:39 25_06_OPL_1280x720_Seg03

CDMO SOWs Must (Re-)Align With New Project Realities

5:31 25_06_OPL_1280x720_Seg09

It's Not What You Deserve, It's What You Negotiate

4:48 25_06_OPL_1280x720_Seg04

Budgeting Key Component In Biologics Flexibility At CDMOs

1:30 25_06_OPL_1280x720_Seg02

An Intro To CDMO Flexibility

2:27 25_06_OPL_1280x720_Seg01

Outsourcing Biologics Comes With "Demands"

1:40 25_06_OPL_1280x720_Seg05

Negotiating With Your CDMOs

3:47 25_06_OPL_1280x720_Seg08

Where CDMOs Can Improve For CGT Customers?

2:38 25_06_OPL_1280x720_Seg07

Are You Asking For Unrealistic Flexibility At Your CDMO?

1:00:07 25_06_OPL_1280x720_Vid

Biologics Development At CDMOs Demands More Flexibility

Outsourced Pharma Live Page

OUTSOURCING FUNDAMENTALS

2:54 China Globe World

Global Advantage With Free Trade Zones In China

0:30 GettyImages-1146473276-team-collaboration-partnership-discussion

Fostering CDMO Collaboration On Both Sides

0:30 GettyImages-1413600685-lab-team-collaboration-computer-research

Visionary Thinkers And Problem Solvers: The Cambrex Team

0:30 Scientist in lab GettyImages-872025342

Collaborating To Craft Efficient Processes

2:42 Map global Logistics GettyImages-1202209630

Commercial Drug Sourcing For Clinical Trials

2:33 GettyImages-171136123-japan

The Ultimate Guide To Clinical Supplies For Japan Studies

4:15 The Leader In Fill Finish

The Leader In Fill/Finish

1:13 23_10_OPL_Challenges_Webinar_Seg01

Workforce Challenges Key To Outsourcing

4:15 23_10_OPL_Challenges_Webinar_Seg02

Managing Multiple Partners – And Materials – From Around The Globe

4:23 Catalent-DTP

Understanding Options In Direct-To-Patient Clinical Supply

1:35 Ampoule Aseptic Filling GettyImages-1490244818

Delivering Top Quality Fill Finish Manufacturing

More Outsourcing Fundamentals Videos

BUSINESS OF BIOTECH

32:40 24_01_BoB_1280x720_Ep261

BoB Live At BIO: Amber Salzman, Ph.D., Epicrispr Biotechnologies

56:34 24_01_BoB_1280x720_Ep260

How To Be A Policy Advocate For Biotech With NewYorkBIO's Jennifer Hawks Bland

1:04:33 24_01_BoB_1280x720_Ep259

FDA Trials And Tribulations With Connect Biopharma's Barry Quart

58:23 24_01_BoB_1280x720_Ep258_2

Proactive Procurement Strategies For Biotech With Tom Wells

1:06:27 24_01_BoB_1280x720_Ep257

The Discovery Of Microbes And Implications For Public Health Today, With Science Writer Thomas Levenson

55:50 24_01_BoB_1280x720_Ep256

Psychedelics For Mental Health Disorders With atai's Srinivas Rao, M.D., Ph.D.

56:27 24_01_BoB_1280x720_Ep255

Biotech Angel Investing With Yaniv Sneor

59:23 24_01_BoB_1280x720_Ep254

Leading A tRNA Startup With Alltrna's Michelle Werner

39:45 24_01_BoB_1280x720_Ep253

Executing A Product Pivot With Vir's Mark Eisner, MD

55:54 24_01_BoB_1280x720_Ep252

Commercializing RNAi Therapies With Alnylam's Tolga Tanguler

55:45 24_01_BoB_1280x720_Ep251

Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie

46:08 24_01_BoB_1280x720_Ep250

The Implications Of China's Growing Biotech Industry With Allan Shaw

44:20 24_01_BoB_1280x720_Ep249

How To Be A CFO With Insmed's Sara Bonstein

46:43 24_01_BoB_1280x720_Ep248

Deal And Investment Trends With Investment Banker David Sans

34:44 24_01_BoB_1280x720_Ep247

Business of Biotech 2.0 with Ben Comer

43:32 24_01_BoB_1280x720_Ep246

BoB@JPM: Nima Farzan, Latigo Biotherapeutics

43:46 24_01_BoB_1280x720_Ep245

BoB@JPM: Kasper Roet, Ph.D., QurAlis

52:20 24_01_BoB_1280x720_Ep244

BoB@JPM: Rick Modi, Affinia Therapeutics

56:27 24_01_BoB_1280x720_Ep243

BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty

47:59 24_01_BoB_1280x720_Ep242

BoB@JPM: Tom Chalberg, Ph.D., Genascence

37:00 24_01_BoB_1280x720_Ep241

BoB@JPM: Ran Zheng, Landmark Bio

45:07 24_01_BoB_1280x720_Ep240

BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics

43:00 24_01_BoB_1280x720_Ep239

BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience

47:50 24_01_BoB_1280x720_Ep238

The Business Of CNS with Acumen's Jim Doherty, Ph.D.

1:13:36 24_01_BoB_1280x720_Ep237

High-Throughput Discovery With BIOPTIC's Andrey Dobry

1:06:32 24_01_BoB_1280x720_Ep236

RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D.

54:04 24_01_BoB_1280x720_Ep235

Biotech Story Time With Tal Zaks, M.D. (Part 2)

1:02:34 24_01_BoB_1280x720_Ep234

Risk Mitigation With MeiraGTx's Zandy Forbes, Ph.D.

55:25 24_01_BoB_1280x720_Ep233

Biotech Story Time With Tal Zaks, M.D. (Part 1)

52:50 24_01_BoB_1280x720_Ep232

A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.

1:03:50 24_01_BoB_1280x720_Ep231

Manufacturing Partnership With Life Biosciences Jerry McLaughlin and Forge Biologics' John Maslowski

45:26 24_01_BoB_1280x720_Ep230

Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D.

49:54 24_01_BoB_1280x720_Ep229

Biopolitics With Allan Shaw

1:01:35 24_01_BoB_1280x720_Ep228

T-Cells For The Win With Adaptimmune's Adrian Rawcliffe

46:48 24_01_BoB_1280x720_Ep227

Serving The Underserved With Gates MRI's Claire Wagner, M.D.

49:12 24_01_BoB_1280x720_Ep226

An Unanticipated Biotech Startup With OS Therapies' Paul Romness

44:14 24_01_BoB_1280x720_Ep225

Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright

1:02:40 24_01_BoB_1280x720_Ep224

Obesity Tx End-Around With Skye Bioscience's Punit Dhillon

51:34 24_01_BoB_1280x720_Ep223

Biotech C-Suite Construction With Allan Shaw

59:19 24_01_BoB_1280x720_Ep222

The Peptide Promise With NervGen's Mike Kelly

1:17:16 24_01_BoB_1280x720_Ep221

Biotech Course Correction With Treehill Partners' Ali Pashazadeh

1:14:26 24_01_BoB_1280x720_Ep220

An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.

54:05 24_01_BoB_1280x720_Ep218

Embracing Biotech Chaos With Memo's Erik van den Berg

1:04:47 24_01_BoB_1280x720_Ep217

Pivoting To RNA With Circio's Dr. Erik Digman Wiklund

1:03:07 24_01_BoB_1280x720_Ep216

mRNA Upstarts With Radar Therapeutics' Sophia Lugo and Eerik Kaseniit, Ph.D.

58:06 24_01_BoB_1280x720_Ep215

Steering Through Setbacks with AVEO Oncology's Michael Bailey

59:37 24_01_BoB_1280x720_Ep214

Leading From Within with ISCT & Kiji's Miguel Forte, M.D.

56:38 24_01_BoB_1280x720_Ep212

Expanding The Proteome with ProFound's John Lepore, M.D.

1:06:39 24_01_BoB_1280x720_Ep211

From The Bench To The Boardroom with ImmunityBio's Enrique Diloné

1:08:52 24_01_BoB_1280x720_Ep210

First AI Antibody In Humans with Aulos' Aron Knickerbocker

1:12:31 24_01_BoB_1280x720_Ep209

Drug Delivery Differentiators with Syncromune's Eamonn Hobbs

58:06 24_01_BoB_1280x720_Ep208

Topical Ocular Biologics with Claris Bio's Clarke Atwell

1:04:08 24_01_BoB_1280x720_Ep206

True DEI Value in Biopharma with Arcellx's Rami Elghandour

22:57 BoB_Ep204_Ch02

How Daiichi Sankyo Revitalized ADCs

55:45 24_01_BoB_1280x720_Ep205

Mission-Driven Dementia Funding with DDF's Jonathan Behr

26:07 BoB_Ep203_Ch02

How Is Mythic Therapeutics Transforming The ADC Space?

1:04:06 24_01_BoB_1280x720_Ep204

ADCs Ignited with Daiichi Sankyo Inc.'s Ken Keller

56:38 24_01_BoB_1280x720_Ep203

Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.

12:15 BoB_Ep196_Ch04

What's Next For Ampersand Biomedicines?

12:15 BoB_Ep196_Ch03

Marrying Computational Biology To Biotech Science

14:15 BoB_Ep196_Ch02

How Can ML And AI Improve Drug Development Success Rates?

13:55 BoB_Ep196_Ch01

Jason Gardner: From GSK To Ampersand Biomedicines CEO

22:42 BoB_Ep198_Ch03

Best Practices To Building And Funding A Successful CRISPR-Based Company

18:15 BoB_Ep198_Ch02

Ups And Downs Of The Biotech Industry

19:20 BoB_Ep198_Ch01

How Tome Biosciences' Rahul Kakkar Balances Medical Practice, Biotech Leadership, and Venture Capital Advising

7:52 BoB_Ep199_Ch02

How Orna Pioneered Circular RNA Drug Development

22:18 BoB_Ep199_Ch04

What Are The Challenges To Running An RNA Biotech?

17:19 BoB_Ep199_Ch03

What Are The Advantages Of Circular RNA?

11:25 BoB_Ep199_Ch01

How Orna Therapeutics' Tom Barnes Got Into RNA Drug Development

57:35 24_01_BoB_1280x720_Ep202

The Anti-CDMO with CTMC's Jason Bock, Ph.D. and KSQ's Thomas Leitch

11:10 BoB_Ep200_Ch03

What's Next For Anima Biotech?

30:10 BoB_Ep200_Ch02

How Can AI Revolutionize Biotech?

17:18 BoB_Ep200_Ch01

Amina Biotech's Yochi Slonim On Tech-Enabled Drug Discovery

10:12 BoB_Ep201_Ch03_2

How Can Biotech Industry Leaders Build Public Trust?

8:29 BoB_Ep201_Ch02_2

Will Direct-To-Consumer Options Solve The Drug Price Problem?

21:00 BoB_Ep201_Ch01

Why Does The Pharmaceutical Supply Chain's Last Mile Have Broken Links?

59:10 24_01_BoB_1280x720_Ep200

New Apps For AI in mRNA With Anima Biotech's Yochi Slonim

59:11 24_01_BoB_1280x720_Ep199

Circular RNA with Orna Therapeutics' Tom Barnes, Ph.D. and Advancing RNA's Anna Rose Welch

1:01:30 24_01_BoB_1280x720_Ep198

Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D.

56:54 24_01_BoB_1280x720_Ep197

Commercial Readiness with ImmunityBio's Bobby Reddy, M.D.

49:47 24_01_BoB_1280x720_Ep196

Precision Drug Delivery with Ampersand Biomedicines' Jason Gardner, Ph.D.

40:16 24_01_BoB_1280x720_Ep195

Funding Alzheimer's Tx Dev with ADDF's Karen Harris

1:13:54 24_01_BoB_1280x720_Ep194

The AI Impact with Generate:Biomedicines' Mike Nally

47:52 24_01_BoB_1280x720_Ep193

Strategic Deals With CinRx's Gavin Samuels, M.D.

31:32 24_01_BoB_1280x720_Ep192

Serial Success With Triumvira's Rob Williamson

50:43 24_01_BoB_1280x720_Ep191_2

The Innovator's Dilemma with Lumen Bioscience's Brian Finrow, J.D.

40:38 24_01_BoB_1280x720_Ep190

Precision Radiopharmaceuticals with Ratio's Jack Hoppin, Ph.D.

51:07 24_01_BoB_1280x720_Ep189

Managing Mergers With Sail's Guillaume Pfefer, Ph.D

45:51 24_01_BoB_1280x720_Ep188

Reprogramming Human Cells With bit.bio's Mark Kotter, M.D.

46:59 24_01_BoB_1280x720_Ep187

Inhalable mRNA With Ethris' Carsten Rudolph, Ph.D.

51:02 24_01_BoB_1280x720_Ep186

Biotech Is Back With Allan Shaw

50:31 24_01_BoB_1280x720_Ep185

Multimodal R&D Management With Incyte's Jim Lee, M.D., Ph.D.

55:03 24_01_BoB_1280x720_Ep184

Building A Biotech Hub With Intellia Therapeutics' John Leonard, M.D.

49:47 24_01_BoB_1280x720_Ep183

Art Of The Pivot With Elevation Oncology's Joe Ferra

51:41 24_01_BoB_1280x720_Ep182

CDMO Collab with Scorpius BioManufacturing's Steve Lavezoli + Fina Biosolutions' Dr. Andrew Lees

1:06:13 24_01_BoB_1280x720_Ep181

Biotech Down Under with BiomeBank's Dr. Sam Costello

1:08:42 24_01_BoB_1280x720_Ep180

IL-2 Program Profits With Bonum's Drs. John Mulligan And Neela Patel

1:03:40 24_01_BoB_1280x720_Ep179

Public Sector Forged, Private Sector Tested With Renovaro BioSciences' Mark Dybul, M.D.

28:13 24_01_BoB_1280x720_Ep178

mRNA Vaccine Platforms With Combined Therapeutics' Dr. Romain Micol

1:02:44 24_01_BoB_1280x720_Ep177

Biotech Dealmaking with Regeneron's Nouhad Husseini

Business of Biotech Page

CELL & GENE PODCAST

20:13 23_12_CGPodcast_1280x720_Ep106

Gene Therapy for Inherited Retinal Diseases with Opus Genetics' Dr. George Magrath

15:58 23_12_CGPodcast_1280x720_Ep105

Extracellular Vesicle Breakthroughs with Aegle Therapeutics' Dr. Gloria Matthews

24:46 23_12_CGPodcast_1280x720_Ep104

Bridging Development and Regulation in CGT with Halloran Consulting Group's Monika Swietlicka

19:28 23_12_CGPodcast_1280x720_Ep103

Harnessing AI and Synthetic Biology for Cell Therapies with Generate:Biomedicines' Dr. Alex Snyder

17:54 23_12_CGPodcast_1280x720_Ep102

Redefining Heart Failure Treatment with Precision Autologous Cell Therapy with BioCardia's Peter Altman, Ph.D.

28:15 23_12_CGPodcast_1280x720_Ep100

Rethinking CGT Biotech Growth & Investment with Audrey Greenberg

14:53 23_12_CGPodcast_1280x720_Ep99

Advancing Retinal Gene Therapy with Atsena Therapeutics' Dr. Kenji Fujita

34:57 23_12_CGPodcast_1280x720_Ep98

Harnessing the Power of Cord Blood Tregs with Cellenkos' Dr. Simrit Parmar

28:42 23_12_CGPodcast_1280x720_Ep97

CGT Manufacturing: Distributed & Digital with Deloitte Consulting's Omkar Kawalekar, Ph.D.

35:38 23_12_CGPodcast_1280x720_Ep96

Inside Gene Therapies for Cardiac Care with Tenaya Therapeutics' Faraz Ali

26:49 23_12_CGPodcast_1280x720_Ep95

The Future of Adenovector-Based Therapies with Precigen's Helen Sabzevari, Ph.D.

24:24 23_12_CGPodcast_1280x720_Ep94

The Future of NK Cell Therapy for Autoimmune Disease with Artiva Biotherapeutics' Christopher Horan

More Cell & Gene Podcast Videos

MOST RECENT OUTSOURCED PHARMA LIVE VIDEO

4:57 25_06_OPL_1280x720_Seg11
The World Outside Influencing Your Outsourcing Internals

Tariffs, geopolitical gyrations, (pending) laws such as the BIOSECURE Act; all affect your outsourcing optionality and decision-making. Our panel of internationally savvy biopharma executives provide some guiding insights.